Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
055/2017 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2016/950 frá 15. júní 2016 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin 2,4-DB, betasýflútrín, karfentrasónetýl, Coniothyrium minitans af stofni CON/M/91-08 (DSM 9660), sýasófamíð, deltametrín, dímetenamíð-P, etófúmesat, fenamídón, flúfenaset, flúrtamón, foramsúlfúrón, fosþíasat, ímasamox, joðsúlfúrón, ípródíón
Durchführungsverordnung (EU) 2016/950 der Kommission vom 15. Juni 2016 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe 2,4-DB, beta-Cyfluthrin, Carfentrazon-ethyl, Coniothyrium minitans Stamm CON/M/91-08 (DSM 9660), Cyazofamid, Deltamethrin, Dimethenamid-P, Ethofumesat, Fenamidon, Flufenacet, Flurtamon, Foramsulfuron, Fosthiazat, Imazamox, Iodosulfuron, Iprodion, Isoxaflutol, Linuron, Maleinsäurehydrazid, Mesotrion, Oxasulfuron, Pendimethalin, Picoxystrobin, Silthiofam und Trifloxystrobin
Kommisjonens gjennomføringsforordning (EU) 2016/950 av 15. juni 2016 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperiodene for de aktive stoffene 2,4-DB, beta-cyflutrin, karfentrazon-etyl, Coniothyrium minitans stamme CON/M/91-08 (DSM 9660), cyazofamid, deltametrin, dimetenamid-P, etofumesat, fenamidon, flufenacet, flurtamon, foramsulfuron, fostiazat, imazamox, jodsulfuron, iprodion, isoksaflutol, linuron, maleinhydrasid, mesotrion, oksasulfuron, pendimetalin, pikoksystrobin, siltiofam og trifloksystrobin
History
18.03.2017
Adopted JCD confirmed entry into force date
18.03.2017
Compliance date in the EEA
17.03.2017
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
01.02.2017
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
15.06.2016
Adoption date in the EU
06.07.2016
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.